Onassis Holdings Stock Price, News & Analysis

Onassis Holdings Corp (OTC: ONSS) is described in its public communications as a wellness and biotech focused holding company. Over time, the company has highlighted activities in wellness, healthcare, biotechnology, longevity and rejuvenation technologies, and the distribution of nutraceuticals and herbal-based medications. According to company press releases, Onassis Holdings has positioned itself around rejuvenation therapy, epigenetic programming, and other anti-aging methods, while also developing and distributing wellness products and CBD vape formulations.

Business focus and operating model

Onassis Holdings Corp presents itself as a holding company that operates through subsidiaries and partnerships in the wellness and biotech sectors. In earlier disclosures, the company stated that it specialized in healthcare, technology and the distribution of nutraceuticals and herbal-based medications, with a focus on the wellness sector and plans for manufacturing new products for this market. It has reported working with nutrition experts and selecting products that have undergone in-vitro and in-vivo clinical studies of herbal and marine formulations used in traditional and natural medicine.

More recent press releases describe Onassis Holdings as a biotech holdings company specializing in longevity and rejuvenation technologies by epigenetic reprogramming. The company has announced an exclusive perpetual license agreement with a leading Israeli university for epigenetic programming technology intended for rejuvenation therapy, and has described plans to develop, manufacture, market, distribute, and sell products utilizing this technology worldwide.

Rejuvenation therapy and epigenetic programming

In its rejuvenation-focused communications, Onassis Holdings states that it is entering the rejuvenation therapy market with epigenetic programming technology. The company describes this as an epigenetic editing technique that targets chemical marks on DNA that influence gene activity. According to the company, these marks accumulate as cells age and contribute to loss of function and age-related diseases. By selectively modifying these marks, the technology is described as having the potential to rejuvenate aged cells, reset the epigenetic clock, and restore more youthful cellular function.

Onassis has also stated that its epigenetic programming technology is aimed at age-related diseases, mentioning conditions such as Alzheimer's disease, Parkinson's disease and age-related macular degeneration in its public materials. The company presents this approach as addressing cellular mechanisms associated with aging, with the goal of improving health and longevity.

Wellness, nutraceuticals and herbal-based products

In addition to its biotechnology and rejuvenation focus, Onassis Holdings has described a line of wellness products and nutraceuticals. Company press releases have listed products such as CimetrA-IMP (described as an investigational medicinal product under an urgent registration process in the United States to treat COVID-19), Co-Blox (a food supplement capsule to support the immune system), Majestix and Majestix Post (syrups based on plant extracts, vitamins and fungi), and ArtemiC Rescue (a food supplement intended to support the immune system with ingredients including artemisinin, Curcuma longa rhizome extract, Boswellia serrata oleo resin and vitamin C).

Onassis has stated that it focuses on distribution of nutraceuticals and herbal-based medications in the wellness sector, with future plans for manufacturing new products. The company has indicated that it selects products that have passed in-vitro and in-vivo clinical studies of herbal and marine formulations used in traditional and natural medicine, and that its herbs are sourced from authentic medicinal material cultivation areas with an emphasis on traceability from harvest to extract.

CBD vapes and Ananda Labs subsidiary

The company has also announced activity in CBD vape products through a subsidiary. According to a press release, Onassis launched sales of Extrax CBD vape formulations, developed in the United Kingdom and marketed as offering different mood experiences. The company stated that all marketing operations for Extrax would be carried out by Ananda Labs Inc., a U.S. subsidiary of Onassis, and that these vapes would be added to its wellness product range and sold in the European Union and North America.

Onassis has described the Extrax CBD vape formula as using broad-spectrum CBD hemp extract combined with cannabis-derived terpenes, and has emphasized design elements such as ceramic heating components and plant-based ingredients. The company has associated these products with body and mind wellness in its communications.

Longevity biotechnology and Ananda Labs

In more recent materials, Onassis Holdings describes itself as a biotech holdings company specializing in longevity and rejuvenation technologies by epigenetics reprogramming. The company states that it holds a subsidiary called Ananda Labs Inc., which focuses on creating a therapy based on patented proteins intended to rejuvenate elderly cells while maintaining their distinct properties. This description connects Ananda Labs directly to the company's longevity and cellular rejuvenation ambitions.

Capital raising and OTC trading

Onassis Holding Corp is identified in its press releases as a U.S. public company trading on the OTC market under the symbol ONSS. The company has repeatedly announced plans to raise capital through Regulation A+ offerings, sometimes referred to as "mini IPO" financings, and has reported retaining Dalmore Group as an investment bank and broker-dealer to support these efforts. It has also mentioned plans for offerings under Regulation D and Regulation S for accredited and international investors.

In its descriptions, Onassis highlights the use of digital platforms and broker-dealer technology to streamline investor onboarding, documentation, payments, investor relations, and data analytics. These capital-raising activities are presented as supporting expansion of operations, management, marketing and research and development.

Partnerships and investor relations tools

The company has announced a partnership with SRAX, Inc. to use SRAX's Sequire platform for investor relations. According to Onassis, this platform provides real-time market data, including level two trading data, and tools for communicating with investors. The company has linked this partnership to its plans for expansion and growth, emphasizing improved communication with its investor community.

Corporate background and location

Onassis Holdings has stated that it is headquartered in New York City, with warehouse and fulfillment offices in Long Island, New York. The company has also disclosed that it was originally incorporated in the State of Nevada in 2004. These details provide context on its corporate history and geographic base.

Industry classification

While external classification data may list Onassis Holdings Corp under gold ore mining and the broader mining, quarrying, and oil and gas extraction sector, the company’s own press releases consistently describe its business as a wellness and biotech focused holding company. Its communications emphasize wellness, healthcare, biotechnology, rejuvenation therapy, epigenetic programming, nutraceuticals, herbal-based medications and CBD vapes, rather than mining activities.